AIM: To confirm the predictive factors for interferon (IFN)-alpha and ribavirin combination therapy for chronic hepatitis patients with hepatitis C virus (HCV) genotype 1b. METHODS: HCV RNA from 50 patients infected with HCV genotype 1b was studied by cloning and sequencing of interferon sensitivity determining region (ISDR), PKR-eIF2alpha phosphorylation homology domain (PePHD). Patients were treated with IFN-alpha and ribavirin for 6 mo and grouped by effectiveness of the therapy. A variety of factors were analyzed. RESULTS: Our data showed that age, HCV RNA titer, and ISDR type could be used as the predictive factors for combined IFN-alpha and ribavirin efficacy. Characteristically, mutations in PePHD appeared only when the combination therapy was effective. Other factors, such as sex and alanine aminotransferase (ALT) level, were not related to its efficacy. Adjusting for age and HCV RNA titer indicated that the ISDR type was the most potent predictive factor. CONCLUSION: HCV RNA ISDR type is an important factor for predicting efficacy of IFN-alpha and ribavirin combination therapy in Korean patients.
Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C. Publishing Authors By Initials
Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C. Journal Published:
PUBLICATION TYPE: Journal Article
Journal: World journal of gastroenterology : WJG
VOLUME: 13
Page Numbers: 6236-42
Journal Abbreviation: World J. Gastroenterol.
ISSN: 1007-9327
DAY: 14
MONTH: Dec
YEAR: 2007
Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 100883448
Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C.
AFFILIATION: Department of Biochemistry, Wonju College of Medicine, Yonsei University, 162 Ilsandong, Wonju, Gangwondo 220-701, Republic of Korea. biyeh64@hotmail.com.
Country: China
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: World J Gastroenterol
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C Related Publications